Risk factors
Telomir Pharmaceuticals (TELO) risk factors
Item 1A of every Telomir Pharmaceuticals, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors65 risks15 new3 dropped7 reworded
Telomir faces significant going concern doubts with zero revenues and a reliance on external financing.
Filed Mar 17, 2026 - FY2024 10-K risk factors53 risks
The company relies entirely on in-licensed pre-clinical asset Telomir-1 without owning underlying patents.
Filed Feb 04, 2025